stock.name

Iovance Biotherapeutics Inc

IOVA

Market Cap$4.29B
Close$

Compare Iovance Biotherapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Iovance Biotherapeutics IncIovance Biotherapeutics Inc00%---
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$14.62

Current Fair Value

3.7% upside

Undervalued by 3.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$4.29 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Beta1.65
Outstanding Shares279,307,043
Avg 30 Day Volume11,143,030

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Iovance Biotherapeutics Inc

CEO: Maria Fardis